Comirnaty 2024 25 Usd. Ema’s human medicines committee (chmp) has recommended authorising an adapted comirnaty vaccine targeting the omicron xbb.1.5 subvariant. Due to the pandemic, the vaccine was initially made available under an emergency use.
Comirnaty is supplied as a frozen suspension in multiple dose. Due to the pandemic, the vaccine was initially made available under an emergency use.